Milestone Pharmaceuticals Inc. (MIST) stock
MISTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.66−0.01 (-1.06%)
Close on Nov 12, 2026Market cap $81.57MP/E –Yield –
Milestone Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Milestone Pharmaceuticals's enterprise value was -$88.16M on Nov 11, 2026, against $146.51M a year earlier. Over the last 5 years it ranged from -$88.16M to $189.55M, with a median of $30.35M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$88.16M | -198.6% |
| 2025 | Dec 31, 2025 | $89.44M | +80.9% |
| 2024 | Dec 31, 2024 | $49.45M | – |
| 2023 | Dec 29, 2023 | -$19.79M | -145.9% |
| 2022 | Dec 30, 2022 | $43.14M | -37.7% |
| 2021 | Dec 31, 2021 | $69.25M | +10.3% |
| 2020 | Dec 31, 2020 | $62.77M | -75.4% |
| 2019 | Dec 31, 2019 | $255.60M | – |
See a number that looks wrong?